Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group (Q71873113)
Jump to navigation
Jump to search
scientific article published on 01 November 1996
Language | Label | Description | Also known as |
---|---|---|---|
English | Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group |
scientific article published on 01 November 1996 |
Statements
Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group (English)
J Viallet
D Stewart
F Shepherd
J Ayoub
Y Cormier
N DiPietro
1 November 1996